When my father developed cancer in 2014, I wasn’t convinced by the treatment methods that were available to us. I then discovered Dendritic Cell Therapy as the most promising option. There are many better treatment options than those recommended today to most patients. With our patients we see the consistent positive results of Dendritic Cell Therapy. Immucura’s mission is to apply the most advanced scientific options to overcome cancer.
Unfortunately for my father it was too late – but everything happens for a reason, and for me it was the motivation to help others.
Johannes E. Schumacher CEO, Immucura Med SL